CDC42BPA and breast cancer: To directly address the role of MRCKα in malignant breast cancer, we generated mice with a constitutive knockout of MRCKα using CRISPR genome editing and investigated their development and, by crossing with MMTV-PyMT mice, the formation of breast cancer.